|Bid||0.00 x 1100|
|Ask||0.00 x 900|
|Day's range||245.20 - 254.96|
|52-week range||220.90 - 281.16|
|Beta (5Y monthly)||1.01|
|PE ratio (TTM)||49.97|
|Forward dividend & yield||2.78 (1.12%)|
|Ex-dividend date||30 Dec 2021|
|1y target est||N/A|
Stryker's (SYK) fourth-quarter results are likely to reflect strong segmental performances at Medsurg, Orthopaedic and Neurotechnology & Spine.
Today we will run through one way of estimating the intrinsic value of Stryker Corporation ( NYSE:SYK ) by taking the...
Stryker (SYK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.